Published in Dig Liver Dis on May 22, 2008
Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms. World J Gastroenterol (2009) 1.02
The clinical utility of FibroScan(®) as a noninvasive diagnostic test for liver disease. Med Devices (Auckl) (2014) 0.87
Tenofovir and its potential in the treatment of hepatitis B virus. Ther Clin Risk Manag (2009) 0.82
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection. Eur J Clin Microbiol Infect Dis (2013) 0.82
Management of HBV infection during immunosuppressive treatment. Mediterr J Hematol Infect Dis (2009) 0.77
The controversial role of lamivudine prophylaxis in occult HBV carriers treated with chemo-immune therapy. Dig Liver Dis (2009) 0.76
Patients with hematological malignancies and serological signs of prior resolved hepatitis B. World J Gastrointest Oncol (2012) 0.75
delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci U S A (1980) 5.12
Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis (1980) 4.28
The delta agent. Hepatology (1983) 3.72
Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope. J Virol (1986) 3.63
Types of 'reticulin' antibodies detected in human sera by immunofluorescence. J Clin Pathol (1973) 2.98
Delta hepatitis agent: structural and antigenic properties of the delta-associated particle. Infect Immun (1984) 2.81
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia (2005) 2.67
Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol (1973) 2.59
The hepatitis B virus-associated delta antigen: isolation from liver, development of solid-phase radioimmunoassays for delta antigen and anti-delta and partial characterization of delta antigen. J Immunol (1980) 2.57
Influence of delta infection on severity of hepatitis B. Lancet (1982) 2.31
Incidence and significance of antibodies to delta antigen in hepatitis B virus infection. Lancet (1979) 2.29
Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers. Lancet (1980) 2.17
Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med (1983) 2.16
Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study. J Hepatol (2007) 2.12
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*. J Viral Hepat (2011) 2.00
Efficacy of amoxycillin plus clavulanic acid-based triple therapy for Helicobacter pylori eradication: a retrospective study. Panminerva Med (2010) 1.99
Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology (1986) 1.75
Hepatic disorders associated with liver-kidney microsomal antibodies. Br Med J (1974) 1.64
Chronic Helicobacter pylori infection and migraine: a case-control study. Headache (2001) 1.54
Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial. Hepatology (1998) 1.53
Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial. Am J Gastroenterol (1999) 1.52
Helicobacter pylori seroprevalence in cirrhotic patients with hepatitis B virus infection. Neth J Med (2000) 1.50
Serological response to the hepatitis delta virus in hepatitis D. Lancet (1987) 1.50
Characterization of the microsomal antigen related to a subclass of active chronic hepatitis. Immunology (1974) 1.50
Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts. Lancet (1982) 1.50
Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal. Am J Gastroenterol (2002) 1.49
Infection with the delta agent in chronic HBsAg carriers. Gastroenterology (1981) 1.48
Incidence of hepatitis delta virus infection in acute HBsAg-negative hepatitis. J Infect Dis (1989) 1.48
Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy. Am J Epidemiol (1983) 1.47
Enzyme-linked immunosorbent assay for detection of antibody to the hepatitis B surface antigen-associated delta antigen. J Clin Microbiol (1981) 1.47
Interferon and amantadine in combination as initial treatment for chronic hepatitis C patients. J Hepatol (2001) 1.43
Monoethyl glycine xylidide (MEGX) test evaluation in primary biliary cirrhosis: comparison with Mayo score. Eur J Gastroenterol Hepatol (1997) 1.42
Efficacy of azythromicin-based triple therapy for Helicobacter pylori infection: a retrospective study. Panminerva Med (2008) 1.39
Infliximab for treatment of steroid-refractory ulcerative colitis. Dig Liver Dis (2002) 1.39
Radioimmunoassay detection of IgM antibodies to the HBV-associated delta (delta) antigen:" clinical significance in delta infection. J Med Virol (1982) 1.38
Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology (2000) 1.34
Ribosomal antibodies detected by immunofluorescence in systemic lupus erythematosus and other collagenoses. Clin Exp Immunol (1974) 1.33
Intrahepatic localization of the surface (HBsAg) and core (HBcAg) antigenic determinants associated with hepatitis B virus in biopsy samples from patients with liver disease. Ric Clin Lab (1976) 1.27
A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B. J Hepatol (1990) 1.24
Complement fixing hepatitis B core antigen immune complexes in the liver of patients with HBs antigen positive chronic disease. Gut (1976) 1.23
Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications. J Viral Hepat (2007) 1.21
Experimental transmission of the delta agent to chimpanzees. Prog Clin Biol Res (1983) 1.21
Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker? Med Hypotheses (2000) 1.20
Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis. J Hepatol (2001) 1.20
Liver transplantation: the Italian experience. Dig Liver Dis (2002) 1.19
Perinatal transmission of the hepatitis B virus and of the HBV-associated delta agent from mothers to offspring in northern Italy. J Med Virol (1982) 1.16
An ultrastructural and immunohistochemical study on the delta antigen associated with the hepatitis B virus. J Pathol (1979) 1.16
The predominance of hepatitis delta virus genotype I among chronically infected Italian patients. Hepatology (1997) 1.16
Immunoperoxidase staining of the HBV-associated delta antigen in paraffinated liver specimens. Pathologica (1982) 1.16
A radioimmunoassay for HBcAg in the sera of HBsAg carriers: serum HBcAg, liver HBcAg immunofluorescence as markers of chronic liver disease. Gastroenterology (1981) 1.15
Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent. Clin Exp Immunol (1983) 1.13
Fatal liver failure following food supplements during chronic treatment with montelukast. Dig Liver Dis (2006) 1.11
Ultrastructural localization and characterization of a ribosomal antibody detected by immunofluorescence in systemic lupus erythematosus. Clin Exp Immunol (1974) 1.10
Delta hepatitis--present status. J Hepatol (1985) 1.08
The Italian experience on paediatric liver transplantation: 1988-1999 report. Dig Liver Dis (2002) 1.06
Long-lasting abatement of HBsAg synthesis induced by acute delta infection. Lancet (1983) 1.05
Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis. J Hepatol (2000) 1.04
Is hepcidin the bridge linking Helicobacter pylori and anemia of chronic infection? A research proposal. Panminerva Med (2004) 1.03
Treatment of hepatitis D. J Viral Hepat (2005) 1.02
Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes. Hepatology (1995) 1.02
Liver transplantation in hepatitis delta virus disease. Lancet (1987) 1.02
Cell-mediated immunity to acetaldehyde in alcoholic liver disease demonstrated by leukocyte migration test. Am J Dig Dis (1978) 1.01
Characterization of antimitochondrial antibodies in health adults. Hepatology (1998) 1.01
Epidemiology of hepatitis delta virus (HDV) infection. Eur J Epidemiol (1985) 1.00
Delta infection and liver disease in hemophilic carriers of hepatitis B surface antigen. J Infect Dis (1982) 1.00
Type D hepatitis: the clinical significance of hepatitis D virus RNA in serum as detected by a hybridization-based assay. Hepatology (1987) 0.99
Clinical significance of antibody to the hepatitis delta virus in symptomless HBsAg carriers. Lancet (1985) 0.99
Covered metal stents for management of inoperable malignant colorectal strictures. Gastrointest Endosc (2000) 0.98
Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D. Hepatology (1991) 0.98
Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity. Gastroenterology (1983) 0.98
Experimental HBV and delta infections of chimpanzees: occurrence and significance of intrahepatic immune complexes of HBcAg and delta antigen. Hepatology (1982) 0.97
A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone. Hepatology (2001) 0.97
Complexes of hepatitis B surface antigen and immunoglobulin M in the sera of patients with hepatitis B virus infection. Infect Immun (1983) 0.96
Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients. Lipids (2001) 0.95
Reperfusion damage to the bile canaliculi in transplanted human liver. Hepatology (1996) 0.95
Infection with the delta agent in children. Gut (1985) 0.95
Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Clinical characterization from idiopathic LKM-positive disorders. J Hepatol (1991) 0.95
Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma. Minerva Gastroenterol Dietol (2005) 0.94
G-cell counts in antral endoscopic biopsies by immunofluorescence. Scand J Gastroenterol (1977) 0.93
Chronic HDV (hepatitis delta virus) hepatitis. Intrahepatic expression of delta antigen, histologic activity and outcome of liver disease. J Hepatol (1988) 0.93
Laboratory evaluation of the patient with liver disease. Eur Rev Med Pharmacol Sci (2004) 0.93
Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation. Clin Immunol (1999) 0.93
Ribavirin treatment for chronic hepatitis D: a pilot study. Liver (1994) 0.93
Incidence and significance of different types of connective tissue antibodies in adult and pediatric gastroenterological disorders. Digestion (1978) 0.92
Changing pattern of chronic hepatitis D in Southern Europe. Gastroenterology (1999) 0.92
Detection of HBV-DNA by in situ hybridization using a biotin-labeled probe. J Med Virol (1985) 0.92
A histological study of hepatitis delta virus liver disease. Hepatology (1987) 0.92
Impact of hepatitis C virus infection on healthy subjects on an Italian island. J Viral Hepat (2000) 0.91
Eradication of Helicobacter pylori infection with proton pump inhibitor-based triple therapy. A randomised study. Panminerva Med (2002) 0.91
Serologic markers with fulminant hepatitis in persons positive for hepatitis B surface antigen. A worldwide epidemiologic and clinical survey. Ann Intern Med (1988) 0.91
A randomized controlled trial of a 12-month course of recombinant human interferon-alpha in chronic delta (type D) hepatitis: a multicenter Italian study. Hepatology (1991) 0.91
Endoscopic ultrasound-fine needle aspiration (EUS-FNA) for pancreatic lesions: effectiveness in clinical practice. Dig Liver Dis (2007) 0.90
Riboprobe assay for HDV RNA: a sensitive method for the detection of the HDV genome in clinical serum samples. J Med Virol (1990) 0.90
Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis. Gastroenterology (1996) 0.90
Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study. Aliment Pharmacol Ther (2005) 0.90
[Intrahepatic cholestasis in hyperthyroidism]. Recenti Prog Med (1991) 0.90
Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance. J Clin Endocrinol Metab (2003) 0.90
The journey from hepatitis to hepatocellular carcinoma. Bridging role of Helicobacter species. Panminerva Med (2001) 0.88